COMMUNIQUÉS West-GlobeNewswire

Devenez membre PREMIUM

Accèdez sans limite aux 15 000 actualités du site
et recevez gratuitement chaque semaine,
la Newsletter Santé log avec les actus Santé à ne pas manquer !

S'abonner
29€ TTC/an

Je suis déjà membre PREMIUM

Se connecter

AVEROA Receives Positive Opinion from the European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD)
02/04/2025 - 11:00
CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and hyperphosphatemia Final European Commission decision expected by June 2025; [...]
Helsinn Group submits a new formulation of AKYNZEO® to the European Medicines Agency (EMA)
02/04/2025 - 11:00
Lugano, Switzerland – April 2, 2025 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of nearly fifty years of commercial execution and a strong focus in supportive care, oncology and [...]
Curium Announces Approval of Generic DTPA - Kit for the Preparation of Technetium Tc 99m Pentetate Injection in the U.S.
02/04/2025 - 06:01
ST. LOUIS, April 02, 2025 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration approved its generic version of the Kit for the Preparation of Technetium Tc 99m Pentetate Injection, often [...]
IBA signe un contrat pour installer une solution Proteus®ONE au Tri-Service General Hospital à Taïwan
02/04/2025 - 07:00
Louvain-la-Neuve, Belgique, le 2 avril 2025 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules et principal fournisseur de solutions de protonthérapie pour le [...]
IBA signs contract for a Proteus®ONE solution to be installed at the Tri-Service General Hospital in Taiwan
02/04/2025 - 07:00
Louvain-La-Neuve, Belgium, April 2 nd , 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the [...]
Zelluna ASA [ZLNA]: Annual Report 2024
02/04/2025 - 07:00
Oslo, Norway, 02 April, 2025 - Zelluna ASA, a company pioneering allogeneic ‘off the shelf’ T Cell Receptor based Natural Killer (TCR-NK) cells for the treatment of cancer, announces that the Board of Directors of [...]
Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay
02/04/2025 - 07:00
PRESS RELEASE 02/04/2025, 07:00 CEST Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay Mechelen, Belgium, 02 April 2025 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics [...]
CMR Surgical secures more than $200M to accelerate growth
02/04/2025 - 08:00
CMR Surgical has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity Capital The latest funding will fuel the global commercialisation of its Versius Surgical [...]
Respilean Drops Exposed (MUST-READ): The Truth About Lung Support Big Pharma Doesn’t Want You to Know
02/04/2025 - 02:29
Thousands Are Ditching Inhalers and Breathing Easier with This Surprising Lung Supplement Backed by Nature and Science JUPITER, FLORIDA, April 02, 2025 (GLOBE NEWSWIRE) -- RESPILEAN In a world where we measure [...]
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/04/2025 - 23:30
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for [...]
COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order
02/04/2025 - 01:25
TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“ COSCIENS ” or the “ Company ”), a life science company which develops and commercializes a diversified portfolio [...]
Portsmouth Square Completes Strategic Refinancing of Hilton San Francisco Financial District Hotel
02/04/2025 - 01:55
SAN FRANCISCO, CA, April 01, 2025 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. (OTC: PRSI) ("Portsmouth Square" or "the Company") today announced the successful refinancing of its flagship asset, the Hilton San Francisco [...]
Global Healing’s Oxy-Powder® Demonstrates Powerful Gut Health Benefits in Citruslabs Study
02/04/2025 - 02:21
Global Healing's Oxy-Powder® demonstrated significant digestive health benefits in a recent Citruslabs study, with 95% of participants reporting constipation relief. The ozonated magnesium formula addresses root causes [...]
LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference
01/04/2025 - 21:20
BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025 [...]
Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
01/04/2025 - 21:30
MELBOURNE, Australia, April 02, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX, Telix, the Company) today announces that a first patient has been dosed in the Phase 1 ZOLAR 1 trial of [...]
Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
01/04/2025 - 21:53
Company Announcement COPENHAGEN, Denmark; April 1, 2025 – Genmab A/S (Nasdaq: GMAB) – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]
Conavi Medical Announces Results From Its Annual General Meeting of Shareholders and Adoption of Amendments to Omnibus Equity Incentive Plan
01/04/2025 - 22:00
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“ Conavi Medical ” or the “ Company ”), a commercial stage medical device company focused on designing, manufacturing, and [...]
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01/04/2025 - 22:01
REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that on March 23, 2025, [...]
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
01/04/2025 - 22:01
SCOTTSDALE, Ariz., April 01, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical” or the “Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and [...]

Pages